Quest Diagnostics Incorporated (DGX)

125.21
NYSE
Prev Close 124.51
Day Low/High 123.71 / 126.16
52 Wk Low/High 73.02 / 131.81
Exchange NYSE
Shares Outstanding 134.30B
Market Cap 16.72B
P/E Ratio 23.06
Div & Yield N.A. (N.A)

Latest News

Sector Haves/Have Nots, Lisa Su Does It Again, Trading Tesla and Microsoft

Sector Haves/Have Nots, Lisa Su Does It Again, Trading Tesla and Microsoft

Earnings reports continue to outperform, but can this support equity markets at these levels now?

Use DRIPs to Build a Socially Responsible Portfolio

Use DRIPs to Build a Socially Responsible Portfolio

Many quality companies that fit into the socially responsible investing camp offer direct-purchase plans, allowing investors an easy way to build an SRI portfolio.

Fibocall: Technical Trading Texts

Mid-Caps Outperform, Funding 'Paycheck Protection', U.K. Vaccine Trials

Mid-Caps Outperform, Funding 'Paycheck Protection', U.K. Vaccine Trials

Trading volumes dropping on major indexes, U.K. teams begin human trials on a Covid-19 vaccine, and the U.S. Senate wants another stimulus package addition.

Healthy Upside Potential In Medical Devices and Services Stocks

Healthy Upside Potential In Medical Devices and Services Stocks

Some of the best opportunities are in lesser-known niche markets such as medical devices and services.

Earnings Volcano Erupts, Locking In on Lam, and Apple-Intel Intel: Market Recon

Earnings Volcano Erupts, Locking In on Lam, and Apple-Intel Intel: Market Recon

Also, defense industry names can breathe easier with word of debt ceiling and federal spending deal.

3 Ways to Play Facebook Ahead of Wednesday's Earnings

3 Ways to Play Facebook Ahead of Wednesday's Earnings

Here are some options strategies for this FANG name into tomorrow's report.

Jim Cramer: Stocks That Do Well In a Declining Rate Environment Are Back

Jim Cramer: Stocks That Do Well In a Declining Rate Environment Are Back

The crash of oil will only accelerate the move.

Starbucks Leaves a Bitter Taste and Doesn't Suit My Investment Palate Either

Starbucks Leaves a Bitter Taste and Doesn't Suit My Investment Palate Either

For my portfolio, you can't beat this SBUX competitor -- and for a cup of coffee.

The Really Big Money Rushes to Super Bowl

The Really Big Money Rushes to Super Bowl

This will be the ninth consecutive year when the big game tops that 100 million-viewers mark.

Cramer: There Are Powerful Themes in Several Bull Markets

Cramer: There Are Powerful Themes in Several Bull Markets

It's a wonder to me how split this market really is.

Stanley Black & Decker, Quest Diagnostics and 2 More Could Rocket Higher This Spring -- Here's Why

Stanley Black & Decker, Quest Diagnostics and 2 More Could Rocket Higher This Spring -- Here's Why

These four stocks are showing short-term gain catalysts and longer-term growth potential.

Quest Diagnostics Investigates Third-Party Data Breach

Quest Diagnostics Investigates Third-Party Data Breach

Shares of Quest Diagnostics were slightly higher Tuesday after announcing an investigation into a data breach by a third-party that affected the health records of 34,000 people.

Exxon Mobil CEO is Trump's Choice for Secretary of State

Exxon Mobil CEO is Trump's Choice for Secretary of State

The 64 year old Tillerson became CEO of the Texas based oil giant in 2004 and has a close business relationship with Russian President Vladimir Putin.

Quest Diagnostics upgraded at Goldman

Quest Diagnostics CEO on Donald Trump's Plan to Overhaul Obamacare

Quest Diagnostics CEO on Donald Trump's Plan to Overhaul Obamacare

Quest Diagnostics CEO Stephen Rusckowski discusses the Affordable Care Act and what's next for his company.

Bullish and Bearish Reversals for the Week

Bullish and Bearish Reversals for the Week

Here's a window into what institutional investors may be doing and how to profit from that.

Cramer: These Stocks Are the Key to the Bull Market

Cramer: These Stocks Are the Key to the Bull Market

Let me give you the unassailable themes.

Laboratory Corp. of America Looks Pretty Healthy

LH's $5.7B Covance takeover could be just what the doctor ordered.

Quest Diagnostics Is on a Mission to Rally

Quest Diagnostics Is on a Mission to Rally

Charts show DGX should break out above resistance soon.

Theranos Must Refute Claims Specifically

Questions will continue to swirl until facts emerge.

Quest DIagnostics upgraded at Wells

Quest Diagnostics Can't Stop the Bleeding; 10% Slide in Sight

Quest Diagnostics Can't Stop the Bleeding; 10% Slide in Sight

Quest could be vulnerable to a deep correction, but a decline to next support around $60 seems like the path of least resistance. 

Jim Cramer Says Blackberry Needs a Catalyst, TransUnion Will Be a Buy

Jim Cramer Says Blackberry Needs a Catalyst, TransUnion Will Be a Buy

Jim Cramer answers viewers’ Twitter (TWTR) questions from the floor of the New York Stock Exchange.